AstraZeneca Looks To China For Growth - But CEO Says Spinoff Not Happening
AstraZeneca is the largest foreign owned pharmaceutical company in China based on revenue, and they’re continuing to increase investment in the country
Disclaimer : We make no assurance about the completeness and accuracy of the content of this website. All news on this website is collected from various sources hence information may or may not be true. Money Nations does not verify the reliability of the content published. We do not accept any accountability for loss or damage occurred as a result of reliability on the content of this website.